Regarding “Early carotid endarterectomy in symptomatic patients is associated with poorer perioperative outcomes”  by Naylor, A. Ross
population with larger ulcers would require greater re-epi-
thelialization and more skin grafting.
As we already suggested in the article, the existence of
prognostic keys in wound healing, such as the ulcer surface, are
known. Multivariate analysis was performed using Cox’s pro-
portional hazards model to adjust for small imbalances in the
baseline distribution of relevant prognostic factors to wound
healing. Hazard ratios and their 95% confidence intervals (CI)
to the ulcer areas between both groups show indeed a close but
no significant difference.
4. The primary endpoint measurement is time to complete epithe-
lialization, subdivided into two phases; the wound preparation
time following debridement and time to complete healing
following skin application. Critical to the difference in median
healing times (VAC 29 days vs control 45 days) is the delayed
application of skin in the control group (VAC 7 days vs control
17 days). The methodology states that 100% granulation and
minimal exudate was required during wound preparation be-
fore applying skin grafts. The results of the trial are therefore
influenced greatly by the assessment of these two parameters by
two observers. The amount of wound exudate would normally
be estimated by inspection of dressings, not possible in the VAC
group. It is unclear if both observers assessed all wounds,
whether they were independent of each other and, if so, the
degree of concordance.
The assessment of wound fluid is indeed one of the critical
key factors to determine the preparation stage. During the VAC
procedure this assessment is even easier to determine because
the collection canister, hidden in the pump, can be inspected
very easily.
5. Further, we deduce from the results that median healing times
following skin application were similar for both groups (VAC
22 days vs controls 28 days) despite better initial skin graft
survival in the VAC group.
That’s correct. Proves this conclusion the necessity of VAC
even after the transplantation? New studies with cross-over
need to be done to answer this question.
6. Complication rates, including “cutaneous damage,” were
higher in the VAC group vs controls (40% vs 23%), not statis-
tically significant. However, this analysis would be altered if the
two patients in the control group with “bleeding” from donor
sites, complications not related to recipient ulcers, or differ-
ences in therapy, were omitted.
The complication rates between both groups are indeed
not significant. However, the complication “bleeding from the
donor site” is indeed not related to the wound therapy choice
and, therefore, should not be included. Analyzing the compli-
cation rates without the “bleeding from the donor site,” would
show a significant difference caused by the cutaneous damage
due to VAC therapy, whereas drapes to seal the ulcers will
irritate the wound borders.
Hopefully, these answers elucidate all questions and mis-
understandings in our study.
Jeroen D. Vuerstaek, MD
DermaClinic
Genk, Limburg, Belgium
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Regarding “Early carotid endarterectomy in
symptomatic patients is associated with poorer
perioperative outcomes”
In their review of outcomes after carotid endarterectomy
(CEA), which included stratification for time from event to sur-
gery, Rockman et al1 observed that “patients who underwent CEA
4 weeks of ipsilateral TIA/stroke experienced a significantly
increased rate of perioperative complications compared with pa-
tients who underwent CEA in a more delayed fashion.” It was,
thereafter, suggested that a waiting period of 4 weeks be recom-
mended in “stroke patients who were candidates for CEA.” This
interpretation was subsequently challenged2 as being contrary to
pooled analyses from the European Carotid Surgery Trial (ECST)
and the North American Symptomatic Carotid Endarterectomy
Trial (NASCET),3 which showed that the benefit from CEA was
maximal in symptomatic patients operated on within 2 weeks of
the index event.
In responding, Rockman4 did seem to concede this that this
criticism might be true (“clearly Richards and colleagues are cor-
rect that our results were markedly different from a number of
studies including the ECST and NASCET”). By contrast, I would
like to suggest that not only are both groups correct in their
interpretation of contemporary data, but that there is an evenmore
important message from the New York series.
The Carotid Endarterectomy Trialists Collaboration (CETC)
combined data from 5893 patients randomized in ECST,
NASCET, and the Veterans Administration (VA) study having
remeasured all prerandomization angiograms using the NASCET
method.3 The Table3,5 details long-term stroke prevention (per
1000 CEAs at 5 years) relative to the delay to surgery. As is clearly
seen, the benefit from CEA does appear maximal in the first 2
weeks, thus not seeming to support Rockman’s conclusion.
However, what both groups have missed is the fact that by
operating early (even with a higher initial risk), one may still be
preventing more strokes in the long term. The Figure includes the
same data used to produce the Table, but now with stratification
for variations in the operative risk.5 Not withstanding the limita-
tions of secondary analyses, this figure suggests that even if a
surgeon were to perform CEA 2 weeks of the index event with a
10% procedural risk, which many would consider unacceptable, it
is still possible that he or she might be preventing more strokes in
the long term than if surgery were deferred for4 weeks and then
performed with no risk!
At a time when “beauty contests”—who can do surgery or
angioplasty with the lowest procedural risk— are beginning to
dominate media reporting, wemust never lose sight of the fact that
although a delay to intervention may produce better outcomes for
the surgeon or interventionist, this may be at the cost of poorer
long-term outcomes for the patient.
Finally, howmany of you JVS readers silently mocked the poor
results from the angioplasty arm of the French EVA-3S trial, while
failing to notice that 40% of treatments were performed 4
weeks of the index event?6 I would, therefore, respectfully suggest
that the 5% procedural risk incurred by the New York group whilst
Benefit conferred by carotid endarterectomy in
symptomatic patients with 50% to 99% stenoses stratified
for “time from event to surgery”*
Delay to CEA
(weeks)
Patients,
n
Strokes prevented/
1000 CEAs at 5 years
2 weeks 1183 185
2-4 weeks 1054 98
4-12 weeks 2312 55
12 weeks 1344 8
CEA, Carotid endarterectomy.
*Based on a reworking of data from the Carotid Endarterectomy Trialists
Collaboration, who combined the European Carotid Surgery Trial (ECST)
and the North American Symptomatic Carotid Endarterectomy Trial
(NASCET), and Veterans Administration databases, having remeasured all
prerandomization angiograms using the NASCET method.3,5
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operating on symptomatic patients 4 weeks of presentation is to
be strongly commended!
A. Ross Naylor, MD, FRCS
Leicester Royal Infirmary
Leicester, United Kingdom
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Reply
We greatly appreciate the interest of Professor Naylor and his
insightful comments on our article “Early carotid endarterectomy
in symptomatic patients is associated with poorer perioperative
outcomes,” (J Vasc Surg 2006;44:480-7) and on our published
results. Certainly, it was an acknowledged limitation of our manu-
script that we, unfortunately, did not have information on recur-
rent cerebrovascular events that may have occurred in patients
subjected to an arbitrary “waiting period” before carotid endarter-
ectomy (CEA) after an initial stroke.
In addition, we certainly agree wholeheartedly with Professor
Naylor regarding his point that one’s objectives should be to
provide the best long-term outcome for the individual patient, and
not simply to try to attain the lowest periprocedural complication
rate in an attempt to win a “beauty contest.” His comment that
even a 10% procedural risk with surgery performed2 weeks of an
index stroke might prove worthwhile in the long term is certainly
thought provoking, and may very well be perfectly true.
However, another focus of our work was to focus on the
mechanisms of perioperative stroke in patients operated on soon
after an index stroke, and analysis in an attempt to define which
stroke patients (if any) might be better served with delayed inter-
vention as opposed to an earlier approach. We were hopeful that
this information might help clinicians decide the optimal time to
intervention on each individual patient to provide that patient the
best long-term outcome. The relatively high incidence of periop-
erative morbidity due to cerebral hyperperfusion or hemorrhage,
or both, in some stroke patients who underwent early intervention
was concerning to us; unfortunately, I do not believe at this point
that it is possible to predict this outcome with any degree of
accuracy in an individual case.
Regarding the EVA-3S results and the high rate of early
intervention in the angioplasty arm of this trial, I would agree that
this may be partially responsible for the “poor” outcome in these
cases. I will also note results from an abstract to be presented at this
year’s Annual SVS Meeting by McPhee and colleagues from the
University of Massachusetts and Temple University Medical
School.1 In analysis of 217,468 patient discharges from the Na-
tionwide Inpatient Sample after revascularization for carotid artery
stenosis, this study abstract reports a 9.5% periprocedural mortality
rate after carotid artery angioplasty and stenting (CAS) for patients
with a diagnosis of stroke, as opposed to a 2.0% perioperative
mortality rate after CEA. In light of Professor Naylor’s comments,
one wonders whether CAS is generally being performed earlier
after stroke than CEA.
Caron Rockman, MD, FACS
Associate Professor of Surgery
New York University Medical School
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Regarding: “A modified calculation of ankle-brachial
pressure index is far more sensitive in the detection of
peripheral arterial disease”
We read with great interest the report by Dr Schröder et al1 on
a new mode of ankle-brachial index (ABI) calculation. Accord-
ingly, we believe that ABI measurement should be standardized,
facilitating comparability. Nonetheless, their results suggest a new
mode of ABI determination needing further investigations and
deferring temporarily the proposition of a unique mode of ABI
calculation. Indeed, several studies2,3 have compared different
modes of ABI calculation, but the use of the lowest of both ankle
arteries as the ABI numerator had never been assessed. In their
comparison vs color duplex ultrasound imaging,1 the authors
concluded that the use of the lowest ankle pressure (LAP) instead
of the highest ankle pressure (HAP) could increase the diagnostic
abilities of the ABI to detect peripheral arterial disease (PAD).
Because the generalization of ABI measurement in primary
care is mandatory,4 we have several concerns about a wide use of
this mode of calculation in clinical practice. First, their report1
presents ABI results as below or 0.90, but we do not find any
information on those with a missing arterial signal, which would
lead to an ABI  0. This situation is usually due to an arterial
occlusion but can also be present in case of an arterial hypoplasia,
which may occur for the dorsalis pedis artery in 4% to 12% of the
general population.5 Because the study participants were outpa-
tient vascular patients, an absent dorsalis pedis Doppler signal is
probably due to a diseased artery, but this cannot be extrapolated
to the general population with its lower risk of PAD.
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Fig. Strokes prevented per 1000 CEAs at 5 years stratified for (1)
delay from last event to surgery and (2) 30-day death/stroke rate.
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